Breast augmentation carries a substantially lower risk profile than procedures like BBL, but it isn't risk-free — the three issues below are the ones with real, FDA-documented data behind them.
The most common longer-term complication: scar tissue tightening around the implant, causing firmness or distortion. ASPS cites this as the leading reason for reoperation after breast augmentation.
BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) is a rare cancer of the immune system linked to textured-surface implants specifically, not smooth implants. The FDA maintains updated reporting guidance; it is treatable when caught early via implant removal.
Silicone implant rupture is often 'silent' (no obvious symptom) — the FDA recommends MRI screening starting 5–6 years post-implant and every 2–3 years after, distinct from routine mammography.
Based on FDA breast implant labeling guidance; FDA BIA-ALCL guidance — both cited via drtroell.com's numbered reference list, cross-checked against ASPS's own safety-content pages. · Last checked August 2026 · Full methodology →
Breast augmentation carries a substantially lower risk profile than higher-risk cosmetic procedures, but it isn't risk-free. The three documented issues with real FDA-backed data are capsular contracture, BIA-ALCL (linked specifically to textured-surface implants), and silent rupture, which is why periodic MRI screening is recommended.
BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) is a rare cancer of the immune system linked to textured-surface implants specifically, not smooth implants. The FDA maintains updated reporting guidance; it's treatable when caught early via implant removal.
Saline implant rupture is obvious — the breast visibly deflates as the body harmlessly absorbs the saline. Silicone implant rupture is often 'silent,' with no obvious symptom, which is why the FDA recommends MRI screening starting 5–6 years post-implant and every 2–3 years after.
It's the most common longer-term complication after breast augmentation: scar tissue tightens around the implant, causing firmness or distortion. ASPS cites it as the leading reason for reoperation after the original procedure.